Financial Results (Standalone and Consolidated) for the quarter Ended June 30, 2026.

TRUALT BIOENERGY LIMITED TRU LT™ (FORMERLY KNOWN AS TRUALT ENERGY LIMITED) BIOENERGY \. 0B0 -23255000 I 23255600 m contact@trualtbioenergy.com www.trualtbioenergy.com GSTIN -29AAICT5347A1ZB CIN - L15400KA2021PLC145978 July 28, 2026 BSE Limited, National Stock Exchange of India Limited, Department of Corporate Services, The Listing Department, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Mumbai-400001 Mumbai-400051 Scrip Code: 544545 Symbol: TRUALT Sub: Intimation under Regulation 30(6) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Outcome of Board Meeting held on July 28, 2026. Dear Sir/Madam, Pursuant to our intimation dated July 24, 2026, and in terms of the provision of Regulation 30 of the SEBI Listing Regulations, we wish to inform you that the Board of Directors of TruAlt Bioenergy Limited (the “Company”) at its meeting held today, i.e. Tuesday, July 28, 2026, has inter-alia approved:  Based on the recommendation of the Audit Committee, the Board has approved the Audited (Standalone and Consolidated) Financial Results for the quarter ended June 30, 2026 along with the Limited Review Report thereon. Financial Results together with Limited Review Report issued by M/s N. M. Raiji & Co. are enclosed herewith as an Annexure I. The advertisement will also be published in the newspaper, in accordance with the Regulation 47 of the SEBI Listing Regulations, containing a Quick Response (QR) Code and details of the webpage where the complete financial results of the Company, along with the Limited Review Report, will be available. The meeting commenced at 2:30 p.m. (IST) and concluded at 6:15 p.m. (IST) Further the aforementioned information will also be made available on the Company’s website at www.trualtbioenergy.com We request you to kindly take the above on record. Thanking you, Yours faithfully, For Trualt Bioenergy Limited Monu Kumar Company Secretary and Compliance Officer M. No. 38853 Encl.: As above Registered Office : Corporate Office : Survey No. 166, Kulali Cross, Jamkhandi #15th floor Unit No. N-1504, World Trade Center, Brigade Gateway Campus, Mudhol Road, Bagalkot, Karnataka -587313, India #26/1, Dr Rajkumar Road, Malleswaram West, Bengaluru -560 055 N. M. RAIJI & Chartered Accountants Universal Insurance Building Pherozeshah Mehta Road, Mumbai -400 001. INDIA Telephone : 91 (22) 2082 8646 E-mail : nmr.ho@nmraiji.com Annexure I Independent Auditor's Review Report on Unaudited Consolidated Financial Results of TruAlt Bioenergy Limited for the Quarter Ended June 30, 2026 pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. To The Board of Directors TruAlt Bioenergy Limited 1. We have reviewed the accompanying statement of unaudited consolidated financial results of TruAlt Bioenergy Limited ("the Holding Company") and its subsidiaries - Leafiniti Bioenergy Private Limited and TruAlt Gas Private Limited (the Holding Company and its subsidiaries together referred to as the "Group"), for the quarter ended June 30, 2026, together with the relevant notes thereon, ("the Statement"), being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations"). 2. This Statement, which is the responsibility of the Holding Company's Management and has been approved by the Holding Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 ('the Act'), as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. Scope of the Review 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company personnel responsible for financial and accounting matters, and analytical procedures applied to financial data and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013, and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. We have not performed an audit and accordingly, we do not express an audit opinion. N. M. RAIJI & CO. We also performed the procedures in accordance with Circular No. CIR/ CFO/ CMDI/ 44/ 2019 dated 29 March 2019 issued by SEBI under Regulation 33(8) of the Listing Regulations, to the extent applicable. 4. The Statement includes the financial results of TruAlt Bioenergy Limited - Holding Company and its Subsidiaries - Leafiniti Bioenergy Private Limited and TruAlt Gas Private Limited. Conclusion 5. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard specified under section 133 of the Act, as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations including the manner in which it is to be disclosed, or that it contains any material misstatement. Emphasis of Matter 6. The componentization exercise in respect of Unit 4 of the Holding Company, which was capitalized in February 2026, as part of the conversion from mono feed to dual feed, which is required in terms of Ind AS 16 - Property Plant and Equipment, is in progress. Consequently, the updation of the fixed assets register is pending. Our conclusion is not modified in respect of the said matter. For N. M. Raiji & Co. Chartered Accountants Firm Registration No.: 108296W Vii Baise Partner Membership No.: 039434 UDIN: 2.S039484LHS VFF5I 4 t Place: Bengaluru Date: July 28, 2026 TRU/.LT ® TRUALT BIOENERGV LIMITED BIOENERGY (FORMERLY KNOWN AS TRUALT ENERGY LIMITED) ~ 080-23255000[23255600 S contact@trualtbioenergy.com www.trualtbioenergy.com GSTIN -29AAICT5347 A1 Z B CIN-L15400KA2021PLC145978 CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED 30 JUNE, 2026 (All amounts are in~ lakhs, unless otherwise stated) Quarter Ended Vear Ended Sr. June 30, March 31, June 30, March 31, Particulars No. 2026 2026 2025 2026 Unaudited Audited Unaudited Audited 1 Income (a) Revenue from Operations 62,688.31 59,551.97 30,389.17 1, 72,750.66 (bl Other Income 1,452.48 3,138.70 2,274.15 8,645.25 Total Income 64,140.79 62,690.67 32,663.32 1,81,395.91 2 Expenses (a) Cost of Materials Consumed 33,352.25 49,857.80 7,349.06 1,08,470.95 (b) Purchases of Stock-in-Trade 1,058.68 5,368.75 2,253.69 19,967.15 (c) Changes in Inventories of Finished Goods 4,768.81 (24,352.36) 12,372.19 (16,992.44) (d) Employee Benefits Expense 1,205.63 1,350.45 1,119.73 4,781.69 (e) Finance Costs 4,403.46 4,350.25 3,778.88 16,002.41 (f) Depreciation and Amortisation Expense 2,480.34 2,294.65 2,069.02 8,622.76 (g) Other Expenses 9,027.06 14,396.54 3,140.80 26,493.58 Total Expenses 56,296.23 53,266.08 32,083.37 1,67,346.10 3 Profit before Exceptional Items and Tax (1-2) 7,844.56 9,4 [Showing first 8,000 characters — download PDF for full document]